The use of autologous peripheral blood stem cells as a hemopoietic support during polychemotherapy of children with soft tissue sarcomas.
Intensification of cycle polychemotherapy in disseminated tumors considerably improves the efficiency of complex treatment. Reinfusion of peripheral blood stem cells as a factor of replacement treatment during hemopoietic suppression or disorders is now becoming more and more promising.